147 related articles for article (PubMed ID: 32433177)
1. Urinary Reflux Into the Prostate Gland and Seminal Vesicles: A Potential Pitfall in 18F-FDG and 68Ga-PSMA PET/CT.
Hekimsoy T; Gorur GD; Isgoren S; Uslu H; Demir H
Clin Nucl Med; 2020 Jul; 45(7):536-537. PubMed ID: 32433177
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
4. Intense Uptake in Amyloidosis of the Seminal Vesicles on 68Ga-PSMA PET Mimicking Locally Advanced Prostate Cancer.
Stephens M; Kim DI; Shepherd B; Gustafson S; Thomas P
Clin Nucl Med; 2017 Feb; 42(2):147-148. PubMed ID: 27879490
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer.
Tatar G; Ergül N; Baloğlu MC; Arslan E; Çermik TF
Clin Nucl Med; 2023 Mar; 48(3):e135-e137. PubMed ID: 36723899
[TBL] [Abstract][Full Text] [Related]
6. Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
Erhamamci S; Aslan N
Clin Nucl Med; 2020 Mar; 45(3):e176-e177. PubMed ID: 31977478
[TBL] [Abstract][Full Text] [Related]
7. Potential Impact of
Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG
J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Acar E; Kaya GÇ
Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
[TBL] [Abstract][Full Text] [Related]
9. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
Perez PM; Hope TA; Behr SC; van Zante A; Small EJ; Flavell RR
Clin Nucl Med; 2019 Jan; 44(1):e28-e32. PubMed ID: 30394930
[TBL] [Abstract][Full Text] [Related]
10. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
Demirci E; Sahin OE; Ocak M; Akovali B; Nematyazar J; Kabasakal L
Nucl Med Commun; 2016 Nov; 37(11):1169-79. PubMed ID: 27333090
[TBL] [Abstract][Full Text] [Related]
11. Early dynamic imaging in
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
[TBL] [Abstract][Full Text] [Related]
12. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer.
Fendler WP; Schmidt DF; Wenter V; Thierfelder KM; Zach C; Stief C; Bartenstein P; Kirchner T; Gildehaus FJ; Gratzke C; Faber C
J Nucl Med; 2016 Nov; 57(11):1720-1725. PubMed ID: 27261520
[TBL] [Abstract][Full Text] [Related]
14. Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer.
Barakat A; Yacoub B; Homsi ME; Saad Aldine A; El Hajj A; Haidar MB
Sci Rep; 2020 Feb; 10(1):2705. PubMed ID: 32066750
[TBL] [Abstract][Full Text] [Related]
15. An Unexpected Seminal Vesicle Pitfall in PSMA PET.
Bronte A; Rosales JJ; Torres Roca M; Miñana B; Rodríguez-Fraile M
Clin Nucl Med; 2024 Jun; 49(6):e274-e275. PubMed ID: 38537177
[TBL] [Abstract][Full Text] [Related]
16. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
[TBL] [Abstract][Full Text] [Related]
17.
Basha MAA; Hamed MAG; Hussein O; El-Diasty T; Abdelkhalek YI; Hussein YO; Alasamer AF; Mohamed HAE; Deen DSE; Tantawy EF; Metwally MI; Zaitoun MMA; Aly SA; Altohamy JI; Mohamed AEM; Afifi AHM; Harb O
Abdom Radiol (NY); 2019 Jul; 44(7):2545-2556. PubMed ID: 30963182
[TBL] [Abstract][Full Text] [Related]
18.
Iravani A; Hofman MS; Mulcahy T; Williams S; Murphy D; Parameswaran BK; Hicks RJ
Cancer Imaging; 2017 Dec; 17(1):31. PubMed ID: 29268784
[TBL] [Abstract][Full Text] [Related]
19. 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation.
Chen S; Cheung SK; Wong KN; Wong KK; Ho CL
Clin Nucl Med; 2016 Dec; 41(12):959-960. PubMed ID: 27764046
[TBL] [Abstract][Full Text] [Related]
20. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
Lin CY; Lee MT; Lin CL; Kao CH
Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]